1. Home
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
Brain Cancer - Epidemiology Forecast to 2030

Brain Cancer - Epidemiology Forecast to 2030

  • December 2021
  • 42 pages
  • ID: 5637670
  • Format: PDF
  • GlobalData

Summary

Table of Contents

Search Inside

Brain Cancer - Epidemiology Forecast to 2030

Summary
Primary brain cancer (ICD-10 = C70, C71, C72) is defined as a malignant neoplasm that originates in the central nervous system (CNS), which consists of the brain and spinal cord, including the brain stem (National Cancer Institute, 2021).The American Brain Tumor Association (ABTA) reports that there are over 120 different types of malignant and benign brain tumors (American Brain Tumor Association, 2020).

The type and severity of a brain tumor is defined by the cells from which the tumor originated, as well as by the proliferative potential of the abnormal growth. Only malignant tumors are designated as cancer (National Cancer Institute, 2021).

The report includes a 10-year epidemiological forecast for the diagnosed incident cases and five-year diagnosed prevalent cases of brain cancer segmented.The diagnosed incident cases of brain cancer are further segmented by sex, age (all ages), and type (glioblastoma, meningioma, ependymoma, oligodendroglioma, CNS lymphoma, and others).

Further, the diagnosed incident cases of glioblastoma are also segmented by grade (low-grade glioma and high-grade glioma), origin (primary and secondary), biomarkers (MGMT unmethylated, MGMT methylated, EGFR VIII positive, and EGFR amplification positive), and mutations (IDH1/IDH2 mutation, TERT promotor mutation, BRAF-V600E mutation, and NTRK mutation).

The following data describes epidemiology of brain cancer. In the 8MM, epidemiologists forecast an increase in the diagnosed prevalent cases of brain cancer from 121,646 cases in 2020 to 147,148 cases in 2030, at an AGR of 2.10% over the forecast period. The five-year diagnosed prevalent cases of brain cancer in the 8MM are expected to increase from 243,850 cases in 2020 to 303,136 cases in 2030, with an AGR of 2.43% during the forecast period. Brain cancer is known to be more common in men than in women and shows a bimodal distribution, with an increased incidence among children and an increasing incidence with age. This is shown in forecast for the diagnosed incident cases from 2020-2030 in the 8MM.

Scope
- The Brain Cancer Epidemiology Report provides an overview of the risk factors and global trends of brain cancer in the eight major markets (8MM: US, France, Germany, Italy, Spain, UK, Japan, and urban China).
- The report includes a 10-year epidemiological forecast for the diagnosed incident cases and five-year diagnosed prevalent cases of brain cancer segmented. The diagnosed incident cases of brain cancer are further segmented by sex, age (all ages), and type (glioblastoma, meningioma, ependymoma, oligodendroglioma, CNS lymphoma, and others). Further, the diagnosed incident cases of glioblastoma are also segmented by grade (low-grade glioma and high-grade glioma), origin (primary and secondary), biomarkers (MGMT unmethylated, MGMT methylated, EGFR VIII positive, and EGFR amplification positive), and mutations (IDH1/IDH2 mutation, TERT promotor mutation, BRAF-V600E mutation, and NTRK mutation). The model associated with this report additionally provides diagnosed incident cases of glioblastoma by recurrence.
- The brain cancer epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
- The Epidemiology Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 8MM.

Reasons to Buy
The Brain Cancer Epidemiology series will allow you to -
- Develop business strategies by understanding the trends shaping and driving the global brain cancer market.
- Quantify patient populations in the global brain cancer market to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for brain cancer therapeutics in each of the markets covered.
- Understand magnitude of brain cancer population by subtype, digital vasculopathy, and other internal organ involvement.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Grace helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.

ref:plp2021

Reportlinker.com © Copyright 2022. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on